carbonates has been researched along with Alloxan Diabetes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikolic, I; Saksida, T; Stojanovic, I; Stosic-Grujicic, S; Vujicic, M | 1 |
| Bilgin, MD; Bozkurt, O; Evis, Z; Pleshko, N; Severcan, F | 1 |
| Fenoy, FJ; Hernandez, I; Li Volti, G; Lopez, B; Perez, C; Rodriguez, F; Salom, MG; Stec, DE | 1 |
| Beech, JS; Cohen, RD; Evans, SJ; Going, TC; Iles, RA; Nolan, KM; Williams, SC | 1 |
| Anai, M; Arakawa, K; Asano, T; Endou, H; Ishihara, T; Kanai, Y; Kuronuma, Y; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Tsujihara, K; Ueta, K | 1 |
| Anai, M; Arakawa, K; Asano, T; Kano-Ishihara, T; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Tsujihara, K; Ueta, K | 1 |
| Adachi, T; Iwakura, I; Kitamura, K; Okamoto, Y; Oku, A; Saito, A; Seino, Y; Shihara, N; Tsuda, K; Ueta, K; Yamada, Y; Yano, H; Yasuda, K | 1 |
| Adachi, T; Arakawa, K; Ikezawa, K; Kano-Ishihara, T; Matsumoto, T; Oku, A; Saito, A; Tsuda, K; Ueta, K; Yasuda, K | 1 |
| Adachi, T; Arakawa, K; Kano-Ishihara, T; Matsumoto, M; Oku, A; Saito, A; Tsuda, K; Ueta, K; Yasuda, K | 1 |
9 other study(ies) available for carbonates and Alloxan Diabetes
| Article | Year |
|---|---|
Anti-diabetic actions of carbon monoxide-releasing molecule (CORM)-A1: Immunomodulation and regeneration of islet beta cells.
Topics: Animals; Boranes; Carbonates; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Hypoglycemic Agents; Immunologic Factors; Immunomodulation; Insulin-Secreting Cells; Male; Mice; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2015 |
Early Alterations in Bone Characteristics of Type I Diabetic Rat Femur: A Fourier Transform Infrared (FT-IR) Imaging Study.
Topics: Animals; Carbonates; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Femur; Male; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2016 |
Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
Topics: Animals; Antioxidants; Boranes; Carbon Monoxide; Carbonates; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hemodynamics; Kidney; Male; Metalloporphyrins; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Time Factors; Tyrosine; Vasoconstriction; Vasodilation | 2011 |
Haemodynamic and metabolic effects in diabetic ketoacidosis in rats of treatment with sodium bicarbonate or a mixture of sodium bicarbonate and sodium carbonate.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Pressure; Carbon Dioxide; Carbonates; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Drug Combinations; Hemodynamics; Hydrogen-Ion Concentration; Hydroxybutyrates; Lactates; Magnetic Resonance Spectroscopy; Male; Partial Pressure; Rats; Rats, Wistar; Shock; Sodium Bicarbonate; Sodium Chloride; Time Factors | 1995 |
T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
Topics: Administration, Oral; Animals; Carbonates; Diabetes Mellitus, Experimental; Dogs; Glucose; Glucosides; Humans; Kidney; Male; Mice; Monosaccharide Transport Proteins; Postprandial Period; Rats; Rats, Sprague-Dawley; Sodium; Xenopus | 1999 |
Antidiabetic effect of T-1095, an inhibitor of Na(+)-glucose cotransporter, in neonatally streptozotocin-treated rats.
Topics: Animals; Animals, Newborn; Blood Glucose; Carbonates; Diabetes Mellitus, Experimental; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glucose Transporter Type 1; Glucose Transporter Type 4; Glucosides; Glycosuria; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Microvilli; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Sodium | 2000 |
T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Body Weight; Carbonates; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Glucosides; Glycated Hemoglobin; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Jejunum; Kidney; Male; Monosaccharide Transport Proteins; Organ Size; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Urine | 2000 |
Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocin-induced diabetic rats.
Topics: Animals; Carbonates; Deoxyglucose; Diabetes Mellitus, Experimental; Glucosides; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactic Acid; Male; Monosaccharide Transport Proteins; Muscle, Skeletal; Rats | 2000 |
Antihyperglycemic effect of T-1095 via inhibition of renal Na+-glucose cotransporters in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Carbonates; Diabetes Mellitus, Experimental; Glucosides; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Kidney; Male; Microvilli; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2000 |